A pilot study of umbilical cord blood level of SARS-CoV-2 antibody in new born of mother post COVID -19 vaccination during pregnancy.

A pilot study of umbilical cord blood level of SARS-CoV-2 antibody in new born of mother post COVID-19 vaccination during pregnancy.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230125004

Enrollment

Registered

2023-01-25

Start date

2022-08-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the umbilical cord blood level of SARS-CoV-2 antibody in new born of mother post covid -19 vaccination during pregnancy umbilical cord blood level , SARS-CoV-2 antibody, covid -19 vaccination

Interventions

the participants were pregnant women whom received covid 19 vaccination during pregnancy and the umbilical cord blood were collected immediately after delivery

No Intervention Drug

Covid19 vaccine during pregnancy

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.pregnant women 18-50 years old 2. post covid 19 vaccination during pregnancy 3. delivery at gestational age at least 28 weeks 4. delivery live fetus

Exclusion criteria

Exclusion criteria: cannot collect umbilical cord blood during delivery

Design outcomes

Primary

Measure	Time frame
anti spike antibody at delivery BAU/ml	—

Secondary

Measure	Time frame
Neutralizing antibody at delivery % inhibition	—

Countries

Thailand

Contacts

Public ContactSaipin Pongsatha

Faculty of Medicine , Chiang mai University

saipin.pongsatha@cmu.ac.th0899507292

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026